Journal of Proteomics and Genomics Research

Journal of Proteomics and Genomics Research

Journal of Proteomics and Genomics Research – Aim And Scope

Open Access & Peer-Reviewed

Submit Manuscript
Open AccessProteomicsGenomicsSystems Biology

Aim and Scope

Defining the scientific focus of the Journal of Proteomics and Genomics Research. JPGR publishes evidence that advances proteomics and genomics with clear translational relevance.

Scope Highlights

  • Proteomics, genomics, and multi-omics
  • Biomarker discovery and validation
  • Computational and systems biology
  • Reproducible methods and data reporting

Journal at a Glance

ISSN: 2326-0793
DOI Prefix: 10.14302/issn.2326-0793
License: CC BY 4.0
Peer reviewed open access journal

Scope Alignment

Proteome profiling, genomic discovery, multi-omics integration, biomarker validation, computational proteomics, and translational molecular medicine. We emphasize reproducible pipelines and clinically meaningful evidence.

Publishing Model

Open access, single blind peer review, and rapid online publication after acceptance and production checks. Metadata validation and DOI registration are included.

Aim

JPGR advances proteomics and genomics by publishing research that improves biological understanding and translational outcomes. We prioritize rigorous methodology, validated datasets, and clear analytical reporting.

Manuscripts should demonstrate measurable scientific or clinical impact and support reproducible molecular science.

Scope Overview

The journal covers proteome profiling, genomic discovery, multi-omics integration, biomarker validation, and computational analysis. Submissions should maintain a clear molecular focus and describe the biological or clinical implications of findings.

Interdisciplinary submissions are welcome when molecular methods are central to the study design and outcomes.

Priority Topics

  • Quantitative proteomics and protein interaction networks
  • Genomic discovery and functional genomics
  • Multi-omics integration and systems biology modeling
  • Biomarker discovery and validation for diagnostics
  • Computational proteomics and bioinformatics pipelines
  • Single cell and spatial omics technologies
  • Translational molecular medicine and proteogenomics
  • Emerging mass spectrometry and sequencing platforms

Study Types

  • Original research with validated datasets
  • Systematic reviews and meta analyses
  • Method and technology reports with performance data
  • Cohort studies with molecular endpoints
  • Translational studies linking data to clinical outcomes

Data and Reporting Expectations

Provide transparent methods, clear statistical reporting, and data availability statements. Depositing datasets in recognized repositories is strongly encouraged for reproducibility.

Use reporting standards such as CONSORT, STROBE, or PRISMA where applicable and include software versions for computational workflows.

Translational Relevance

JPGR values studies that connect molecular findings to clinical or biological impact. Clearly describe how proteomic or genomic insights influence diagnostics, therapeutic targeting, or mechanistic understanding.

Validation steps that demonstrate real world applicability strengthen scope fit.

Scope Fit Checklist

  • Molecular focus is clear in title and abstract
  • Methods and outcomes align with study aims
  • Data availability statement is included
  • Ethics approvals and consent documented
  • Clinical or biological implications are explained

Out of Scope

Studies focused solely on non molecular outcomes without a clear proteomics or genomics contribution are out of scope. Manuscripts must demonstrate relevance to molecular discovery or translational insight.

JPGR Commitment

JPGR is committed to rigorous, transparent publishing in proteomics and genomics. We emphasize reproducible methods, complete data statements, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in molecular publishing.